News

Latest FIGO Fistula Surgery Training Initiative Newsletter online!

The latest FIGO Fistula Surgery Training Initiative Newsletter is now online . Click here to subscribe.

Latest issue of PPIUD Initiative Newsletter now online!

The latest FIGO Post-Partum IUD Initiative Newsletter is available here . The Newsletter is produced four times a year, to keep you informed about the activities and progress of the Initiative. Subscribe now to receive the Newsletter directly to your inbox.

FIGO recruiting Project Manager - Global Safe Motherhood (Maternity Cover, 8 months)

FIGO is recruiting a Project Manager for Global Safe Motherhood (Maternity Cover, 8 months) Please click here for full application details. Deadline: 18 April 2017

Pre-eclampsia ‘increases risk of heart disease’

Women who suffered pre-eclampsia during pregnancy are four times more likely to have heart failure in later life, according to new research by Keele University, UK. The study also found that expectant mothers with pre-eclampsia, which presents with high blood pressure and protein in the woman...

Biennial mammograms best after age 50

Screening for breast cancer every two years appears just as beneficial as yearly mammograms for women ages 50 to 74, with significantly fewer false positives, according to new research. The study, conducted by the University of California - San Francisco (UCSF), US, found that this was true even...

Exercise ‘can reduce hot flushes in menopausal women’

New research has shown how regular exercise can help menopausal women lose weight and control symptoms such as hot flushes, even in women who previously led sedentary lifestyles. Scientists from the University of Granada, Spain, who carried out the research, explained that decreased oestrogen...

Just 7% of pregnant women with mental health issues get specialist care

Only seven per cent of women with mental health problems during and after pregnancy in the UK were referred to specialist care, a new survey has revealed. Titled, ‘Maternal Mental Health - Women’s Voices’, which was conducted by the Royal College of Obstetricians and...

Epilepsy medicine taken by pregnant women ‘does not harm baby’s overall health’

Children whose mothers have taken anti-epilepsy medicine during pregnancy do not tend to visit the doctor more often than children who have not been exposed to this medicine in utero, according to a new study from Denmark’s Aarhus University. Previous studies have shown that anti-epilepsy...

New technique ‘could reduce breast cancer screening recall rate’

A new breast cancer detection technique has the potential to reduce the rate at which women are called back for further examinations, according to a new study. In 2011, the US Food and Drug Administration (FDA) approved digital breast tomosynthesis (DBT) for use with full-field digital mammography...

Having five best friends ‘can boost women’s fertility’

New research has revealed that women who have a close-knit circle of five friends could boost their fertility. Professor Robin Dunbar, from Oxford University, UK, revealed that his research suggests that the stress of having to maintain too many friendships may have an effect on female hormones and...

New partnership launched to develop AIDS vaccine

A new partnership has been formed between European and African researchers to develop a new vaccine that can be used to prevent infection with different strains of HIV across the globe. The Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT) will set out to evaluate a new...

Pregnant women more likely to quit smoking when supported from first midwife appointment

Pregnant women are almost twice as likely to quit smoking if they are supported from their first midwife appointment, according to research from the UK’s Newcastle University. Those women are also more likely to have heavier, healthier babies. The researchers evaluated the ‘BabyClear...

New trial offers combination therapy to combat ovarian cancer

A new clinical trial is offering combination therapy to directly kill ovarian cancer cells and teach the immune system to prevent them returning. The clinical trial is focusing on women whose ovarian cancer results from mutated BRCA genes. It combines one drug that kills the ovarian cancer cells...